We are removing TotalEnergies from the Growth Portfolio as it pivots towards the competitive field of renewable energy. Read More
Archive
Filter
You Have Questions, We Have Answers Read More
The environmental cost of supporting blockchain technology sends Bitcoin miners searching for a new home. Read More
The financial markets ignored higher inflation and the COVID Delta variant to hit new highs in June. Read More
Merck recently unloaded its portfolio of drugs that will soon lose their patent protection, freeing up capital to invest in research and development. Read More
It is not inflation that has the stock market on edge anymore; it is the possibility of the economy once again shutting down. Read More
This month’s Personal Finance options recommendation includes two strategies, selling a covered call and selling a naked put on Texas Instruments (Nasdaq: TXN) as described below. If you already own shares of Texas Instruments, then you should consider selling a covered call against that stock position, but if you do… Read More
The key jobs figure to watch is the unemployment rate, which actually ticked higher to 5.9% in June from 5.8% in May. Read More
AbbVie is the least expensive of the world’s 10 largest pharmaceutical companies despite its success in extending Humira’s patent protection for several years. I'm raising our buy limit to $125. Read More
If inflation again rises more than expected in July, we may see a flurry of trading activity that temporarily destabilizes the financial markets until a new equilibrium is established among stocks, bonds, and currencies. Read More